Quantum chemistry and life science sectors reach commercial tipping point, with pharmaceutical and industrial giants partnering with quantum hardware developers to solve molecular problems worth $200B-$500B by 2035.

Quantum chemistry and life science sectors reach commercial tipping point, with pharmaceutical and industrial giants partnering with quantum hardware developers to solve molecular problems worth $200B-$500B by 2035.